HU9503833D0 - Compositions for nasal administration of desmopressin - Google Patents

Compositions for nasal administration of desmopressin

Info

Publication number
HU9503833D0
HU9503833D0 HU9503833A HU9503833A HU9503833D0 HU 9503833 D0 HU9503833 D0 HU 9503833D0 HU 9503833 A HU9503833 A HU 9503833A HU 9503833 A HU9503833 A HU 9503833A HU 9503833 D0 HU9503833 D0 HU 9503833D0
Authority
HU
Hungary
Prior art keywords
composition
desmopressin
nasal administration
container
assembly
Prior art date
Application number
HU9503833A
Other languages
English (en)
Other versions
HUT73776A (en
HU221617B1 (hu
Inventor
Alan Harris
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Ab filed Critical Ferring Ab
Publication of HU9503833D0 publication Critical patent/HU9503833D0/hu
Publication of HUT73776A publication Critical patent/HUT73776A/hu
Publication of HU221617B1 publication Critical patent/HU221617B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
HU9503833A 1993-06-29 1994-06-22 Vizes készítmény dezmopresszin nazális adagolására HU221617B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8489493A 1993-06-29 1993-06-29
PCT/SE1994/000623 WO1995001183A1 (en) 1993-06-29 1994-06-22 Compositions for nasal administration of desmopressin

Publications (3)

Publication Number Publication Date
HU9503833D0 true HU9503833D0 (en) 1996-02-28
HUT73776A HUT73776A (en) 1996-09-30
HU221617B1 HU221617B1 (hu) 2002-12-28

Family

ID=22187889

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9503833A HU221617B1 (hu) 1993-06-29 1994-06-22 Vizes készítmény dezmopresszin nazális adagolására

Country Status (20)

Country Link
US (1) US5498598A (hu)
EP (1) EP0708657B1 (hu)
JP (1) JPH09502425A (hu)
KR (1) KR100193104B1 (hu)
CN (1) CN1101701C (hu)
AT (1) ATE203412T1 (hu)
CA (1) CA2166312C (hu)
CZ (1) CZ282456B6 (hu)
DE (1) DE69427820T2 (hu)
DK (1) DK0708657T3 (hu)
ES (1) ES2158898T3 (hu)
GR (1) GR3036936T3 (hu)
HK (1) HK1000906A1 (hu)
HU (1) HU221617B1 (hu)
NZ (1) NZ268442A (hu)
PL (1) PL176317B1 (hu)
PT (1) PT708657E (hu)
RU (1) RU2135204C1 (hu)
SK (1) SK282844B6 (hu)
WO (1) WO1995001183A1 (hu)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001368A1 (en) * 1993-06-29 1995-01-12 Ferring B.V. Improved synthesis of cyclic peptides
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5916582A (en) * 1996-07-03 1999-06-29 Alza Corporation Aqueous formulations of peptides
GB9614235D0 (en) * 1996-07-06 1996-09-04 Danbiosyst Uk Composition for enhanced uptake of polar drugs from mucosal surfaces
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
JP2001233787A (ja) 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
US6641799B2 (en) 2002-04-03 2003-11-04 Nos Spray, Inc. Nasal spray for decongesting nasal passages
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
AU2003269747A1 (en) * 2002-05-15 2003-12-02 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide
ATE324869T1 (de) * 2003-11-13 2006-06-15 Ferring Bv Blisterverpackung und feste dosierungsform enthaltend desmopressin
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
RU2472539C2 (ru) 2007-08-06 2013-01-20 Аллерган, Инк. Способы и устройства для доставки препарата десмопрессина
CN101372504B (zh) * 2007-08-22 2011-05-18 深圳翰宇药业股份有限公司 一种纯化去氨加压素的方法
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
LT2712622T (lt) 2008-05-21 2016-09-26 Ferring B.V. Burnoje disperguojamas desmopresinas, skirtas nikturijos netrikdomo miego pirminio periodo pailginimui
EP2381923B2 (en) * 2008-12-22 2023-06-07 Acerus Pharmaceuticals USA, LLC Intranasal desmopressin administration
WO2010075327A1 (en) * 2008-12-22 2010-07-01 Serenity Pharmaceuticals Corporation Desmopressin composition
AU2015261630B2 (en) * 2008-12-22 2017-09-14 Acerus Pharmaceuticals USA, LLC Intranasal desmopressin administration
DK3679941T3 (da) 2009-06-18 2022-11-14 Serenity Pharmaceuticals Llc Sikker indgivelse af desmopressin
CN102440957B (zh) * 2011-12-16 2013-09-25 深圳市健元医药科技有限公司 醋酸特利加压素鼻腔喷雾剂及其制备方法
US11324746B2 (en) 2014-12-22 2022-05-10 Arovella Therapeutics Limited Use of anagrelide for treating cancer
WO2024105521A1 (en) * 2022-11-17 2024-05-23 Shilpa Medicare Limited Stable peptide pharmaceutical composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
WO1988005661A1 (en) * 1987-01-30 1988-08-11 Biomed Research Consultants, Limited Vasopressin-based pharmaceutical compositions
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
ATE108326T1 (de) * 1989-01-30 1994-07-15 Corint Ltd Wässerige desmopressin-cmc enthaltende arzneizubereitung.
DE69001991T2 (de) * 1989-11-16 1993-09-23 Phidea Spa Fluessige arzneimittel zur nasalen anwendung, die ein polypeptid als wirksubstanz enthalten.

Also Published As

Publication number Publication date
KR960703339A (ko) 1996-08-17
WO1995001183A1 (en) 1995-01-12
CN1101701C (zh) 2003-02-19
HUT73776A (en) 1996-09-30
HU221617B1 (hu) 2002-12-28
EP0708657A1 (en) 1996-05-01
CZ282456B6 (cs) 1997-07-16
CN1126439A (zh) 1996-07-10
JPH09502425A (ja) 1997-03-11
ES2158898T3 (es) 2001-09-16
NZ268442A (en) 1996-09-25
HK1000906A1 (en) 2002-03-08
SK282844B6 (sk) 2002-12-03
EP0708657B1 (en) 2001-07-25
GR3036936T3 (en) 2002-01-31
DE69427820D1 (de) 2001-08-30
CZ339095A3 (en) 1996-09-11
DE69427820T2 (de) 2001-11-08
RU2135204C1 (ru) 1999-08-27
SK165095A3 (en) 1996-11-06
PL312204A1 (en) 1996-04-01
US5498598A (en) 1996-03-12
ATE203412T1 (de) 2001-08-15
PT708657E (pt) 2001-11-30
CA2166312C (en) 2002-04-23
CA2166312A1 (en) 1995-01-12
KR100193104B1 (ko) 1999-06-15
DK0708657T3 (da) 2001-10-15
PL176317B1 (pl) 1999-05-31

Similar Documents

Publication Publication Date Title
GR3036936T3 (en) Compositions for nasal administration of desmopressin
PL316689A1 (en) Anti-dandruff shampoo
HK1000903A1 (en) Stabilized pharmaceutical peptide compositions
AU3183389A (en) Human relaxin formulation
HUT64567A (en) Method for producing new cyclosporines and preparations containing said compounds as active agent
CA2016659A1 (en) Stabilized compositions containing epidermal growth factor
CA2203033A1 (en) Compounds and compositions for delivering active agents
HUT75089A (en) Compositions containing hyaluronic acid or it's derivatives and pharmaceutical active agent
CA2308513A1 (en) Method and composition for delivering zinc to the nasal membrane
CA2113995A1 (en) Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins
GR1003011B (el) Νεα συνθεση
MX9701170A (es) Composicion antitranspirante en aerosol con poco propulsor.
HU9501801D0 (en) Lactame-compounds as pharmaceutical active component
BG103306A (en) Liquid allendronate compositions
NZ337798A (en) Pharmaceutical compositions containing lamivudine
BG103632A (en) Pharmaceutical compositions containing ibuprophene and domperidon for migraine treatment
YU40398A (sh) Kompozicija nazalnog spreja za davanje sredstva za lečenje odloženog napada emezisa
AU7037591A (en) Stabilization of t-pa pro
AU6520196A (en) Aqueous compositions containing ciprofloxacine, and related use and process
HK1006282A1 (en) Novel liquid compositions based on derivatives of 1, 4 substituted piperidine
MX9703839A (es) Soluciones intravenosas de lubeluzol.
CA2187030A1 (en) Improved anti-dandruff shampoo
IT1263107B (it) Composizioni galeniche a base di calcitonina stabilizzate

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees